This site is intended for healthcare professionals registered to attend the ILCA Virtual Congress 2020 only.

Our Commitment to Oncology

Our Pipeline

Ipsen-oncology-pipeline

 

 

Pipeline and Trials in Progress

The safety and efficacy of these compounds and/or uses under investigation have not been established. Thereis no guarantee that these will receive approval from any health authority or become commercially available in any country for the uses being investigated. Ipsen does not encourage or promote the unapproved use of its products. If not otherwise noted allproducts are global initiatives. ©2020 Ipsen Innovation. ALL-ALL-001735/CBZ-BE-000406. Date of preparation August 2020. Please note that the information in this document is correct as of August 2020 at the time of preparation and may have since changed. Therefore please refer to the ClinicalTrials.gov website for the most up-to-date information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020

This page is intended for healthcare professionals registered to ILCA Virtual Congress 2020 only

Please confirm below that you are a healthcare professional registered to ILCA Virtual Congress 2020.

 

 

I confirm I am a Healthcare Professional registered to ILCA Virtual Congress 2020

I am not a Healthcare Professional registered to ILCA Virtual Congress 2020